GRACE :: Global Resource for Advancing Cancer Education
  • Recent GRACE News & Posts

    • Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
      by  GRACE Video  on  Jul 28, 2014  in  GRACE :: Lung Cancer

      The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation. [powerpress]...  (Read More)

    • NanoString Treatment for Kidney Cancer
      by  GRACE Video  on  Jul 25, 2014  in  GRACE :: Kidney Cancer

      NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them. [powerpress]...  (Read More)

    • Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
      by  GRACE Video  on  Jul 23, 2014  in  GRACE :: Lung Cancer

      Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant. [powerpress] ...  (Read More)

    • How is the Heng Criteria Applied to Kidney Cancer Patients?
      by  GRACE Video  on  Jul 21, 2014  in  GRACE :: Kidney Cancer

      Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses. [powerpress]...  (Read More)

    • Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
      by  GRACE Video  on  Jul 18, 2014  in  GRACE :: Lung Cancer

      The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results. [powerpress] ...  (Read More)

    • What is PD1 and PDL1 in Kidney Cancer?
      by  GRACE Video  on  Jul 16, 2014  in  GRACE :: Kidney Cancer

      Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer. [powerpress]...  (Read More)

    • Zykadia for ALK Positive Lung Cancer: New Drug, New Hope
      by  GRACE Video  on  Jul 14, 2014  in  GRACE :: Lung Cancer

      The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases. [powerpress] ...  (Read More)

    • Upcoming Tweet Chat July 17th: Help us define the benefit of online resources for cancer patients
      by  Dr West  on  Jul 12, 2014  in  GRACE :: Lung Cancer

      We have seen over the past decade that patient self-education and participation in their own care have been steadily increasing with availability of the Internet.¬† It has enabled patients and caregivers to look online for information as well as to connect with other people in the patient community who can provide both knowledge of available t...  (Read More)

    • No Clear Answer for Non-Clear Cell Kidney Cancer
      by  GRACE Video  on  Jul 11, 2014  in  GRACE :: Kidney Cancer

      Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them. [powerpress]...  (Read More)

    • What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
      by  GRACE Video  on  Jul 9, 2014  in  GRACE :: Lung Cancer

      "Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab). [powerpress] ...  (Read More)

Ask Us, Q&A
Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Recent GRACE Forum Replies

Recent GRACE Forum Topics

Other Resources